Trading in Theravance Common Stock Halted SOUTH SAN

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Trading in Theravance Common Stock Halted

SOUTH SAN FRANCISCO, CA--(Marketwired - Apr 17, 2013) - Theravance, Inc. ( NASDAQ : THRX ) today announced that NASDAQ halted trading of Theravance common stock this morning, April 17, 2013. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) meets today to discuss the new drug application (NDA) 204275, for fluticasone furoate (FF) and vilanterol (VI) dry powder inhaler (proposed trade name BREO™ ELLIPTA™), sponsored by GlaxoSmithKline plc (GSK), for the long-term maintenance treatment of airflow obstruction and for reducing exacerbations in patients with chronic obstructive pulmonary disease. FF/VI, an investigational once-daily inhaled corticosteroid/long-acting beta 2 agonist (LABA) combination treatment, is in development under the LABA collaboration between GSK and Theravance, Inc.

About Theravance

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Theravance's key programs include: RELVAR™ or BREO™ ELLIPTA™ (FF/VI), ANORO™ ELLIPTA™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta 2 Agonist), each partnered with GlaxoSmithKline plc, and its oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. For more information, please visit Theravance's web site at www.theravance.com .

THERAVANCE®, the Theravance logo, and MEDICINES THAT MAKE A DIFFERENCE® are registered trademarks of Theravance, Inc.

RELVAR™ or BREO™ ELLIPTA™ (FF/VI) and ANORO™ ELLIPTA™ (UMEC/VI) are investigational medicines and are not currently approved anywhere in the world. RELVAR™, BREO™, ANORO™ and ELLIPTA™ are trademarks of the GlaxoSmithKline group of companies. The use of these brand names has not yet been approved by any regulatory authority.

(THRX-G)

Contact Information: Michael W. Aguiar Senior Vice President and Chief Financial Officer 650-808-4100 investor.relations@theravance.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Paris Baguette Opens New Café in Novato, CA

Updated Category News Views 76

Another Feather in Paris Baguette’s Cap Alright, as far as pastry shops go, Paris Baguette is rolling out those cinnamon rolls like they're planting flags on the moon. They've just added a new café in Novato, California, bringing the artisanal charm of their iconic baked goods to yet another American doorstep. A Local Affair with Big Aspirations The man of the hour,...

Continue Reading
BULL Faces Class Action After Regulatory Fines

Updated Category News Views 151

Webull's Financial Quake Shakes Investors You don't expect to wake up to news of a stock in freefall, but here we are with Webull (NASDAQ:BULL) cratering after some rough compliance problems came to light. On November 5, 2026, Webull's stock tumbled nearly 11% thanks to FINRA slapping them with a $4.2 million fine for failing to keep their anti-money laundering (AML) and...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 62

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 80

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
$10,000 Boost Fuels Nichols College's Archaeological Quest

Updated Category News Views 207

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 120

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 203

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature

Updated Category News Views 208

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 101

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 252

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading
IREN Limited Launches $875 Million Notes Offering

Updated Category News Views 213

IREN Limited Announces Convertible Notes Offering IREN Limited (NASDAQ: IREN) has recently announced its pricing for a significant offering of $875 million aggregate principal amount of 0.00% convertible senior notes due in 2031. This offering is primarily targeted at qualified institutional buyers in compliance with Rule 144A under the Securities Act of 1933. Key...

Continue Reading
Adagene's Clinical Advances: Spotlight on ADG126 Presentations

Updated Category News Views 149

Adagene's Upcoming Presentations on ADG126 Adagene Inc. (NASDAQ: ADAG), a pioneering company in novel antibody-based therapies, is set to make waves at the upcoming Chinese Society of Clinical Oncology (CSCO) meeting. With the main events taking place from September 10 to September 14, Adagene will showcase its innovative product, ADG126, through two significant oral...

Continue Reading
AM Best Increases Credit Ratings for Gulf Insurance Group

Updated Category News Views 97

AM Best Upgrades Credit Ratings of Gulf Insurance Group AM Best has made a significant upgrade to the Long-Term Issuer Credit Ratings (ICR) of Gulf Insurance Group K.S.C.P. (GIG) and Gulf Insurance and Reinsurance Company K.S.C. (Closed) (GIG-Kuwait), elevating their rating from 'a' to 'a+' (Excellent). This upgrade reflects the organization's robust financial health and...

Continue Reading
Alta Equipment Group Preps for Q3 2025Results on Nov 6

Updated Category News Views 181

Alta Equipment Group Prepares for Third Quarter 2025 Results Alta Equipment Group Inc. (NYSE: ALTG) is gearing up to unveil its financial performance for the third quarter of 2025, marking its commitment to transparency and communication with investors. The Company, which specializes in premium material handling, construction, and environmental processing equipment, has...

Continue Reading